Mission & Vision


The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies.

The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

History

Learn about the history of ASGCT from Society founder George Stamatoyannopoulos in an interview from the 20th Annual Meeting.

2020 Strategic Plan

ASGCT is committed to seizing on the tremendous growth in the science and clinical application of gene and cell therapy, supporting the global impact of our work, and strengthening the Society’s infrastructure.

2020

ASGCT Policy Summit

September 23-25, 2020